All Drugs
Other · Combined oral contraceptive pill (COCP) — oestrogen + progestogen

Loette (Ethinyl Estradiol + Levonorgestrel)

Also sold as: Loette, Ovral-L, Triquilar, Femilon, Lady, Mala-N

Pregnancy

Cat X

Lactation

Avoid

Schedule

H

Forms

Tablet: EE 20 mcg + LNG 100 mcg (low-dose, e.g., Loette) +2

Indications

Adult Dosing

Contraception / cycle control

1 tablet PO once daily for 21 days, then 7-day pill-free break (or 28-day pack with 7 placebo tablets)

Start Day 1 of period (immediate protection) or Day 1–5 (use backup contraception for 7 days if starting > Day 1). If pill missed: see counselling.

Maximum daily dose: 1 tablet/day

Pediatric Dosing

Age Range: Post-menarche adolescents (≥16 years recommended for contraception)
Dose: Same adult dose — weight not a factor

Same dosing as adults; bone health and breast development considerations in young adolescents — discuss with specialist

Renal Dose Adjustment

CrCl / eGFRDose Adjustment
Mild-moderate CKDAssess cardiovascular risk — oestrogen-containing pills increase clotting risk; progestogen-only pill or non-hormonal method preferred in significant CKD
Calculate eGFR / CrCl →

Hepatic Adjustment

AVOID in acute or chronic liver disease, liver tumour, or if LFTs abnormal. Contraindicated.

Pregnancy & Lactation

Pregnancy: Category X

CONTRAINDICATED during pregnancy. Does not cause harm if inadvertently taken in early pregnancy (Cochrane review — no teratogenicity confirmed). Stop immediately if pregnancy detected.

Lactation: Avoid

Combined pill (containing oestrogen) suppresses lactation — avoid in breastfeeding especially < 6 months postpartum. Progestogen-only pill (POP — e.g., norethindrone, desogestrel) is compatible with breastfeeding.

Top Drug Interactions

Interacting DrugEffectSeverity
Rifampicin, rifabutinCYP3A4 induction — dramatically reduces contraceptive efficacy. Use additional contraception during and for 4 weeks after rifampicin.Major
Enzyme-inducing anti-epileptics (carbamazepine, phenytoin, phenobarbital, primidone, topiramate > 200 mg)Reduce contraceptive efficacy — use higher-dose pill or non-hormonal methodMajor
St John's Wort (Hypericum perforatum)Reduces contraceptive efficacy — avoidMajor
WarfarinCOCPs may increase or decrease INR — monitor INR when starting/stoppingModerate
LamotrigineCOCPs reduce lamotrigine levels by ~50% — may worsen seizure control; lamotrigine dose may need to increase during pill useMajor

DoctorScribe — AI Medical Scribe

Stop looking up Loette — just speak the prescription

"Loette as per dose, BD for 5 days." DoctorScribe writes the full prescription with brand, strength, frequency, and route — auto-applies pediatric weight-based dosing and renal adjustments. Try the live demo.

Side Effects

Common

  • Nausea (especially first 3 months)
  • Breast tenderness
  • Headache
  • Mood changes (low libido, depression — especially levonorgestrel-containing pills)
  • Breakthrough bleeding (spotting in first months)
  • Weight gain (usually < 2 kg)
  • Reduced menstrual flow (usually beneficial)

Serious / Discontinue If

  • Venous thromboembolism — DVT, pulmonary embolism (absolute risk is small but 3–4× baseline; levonorgestrel pill has lowest VTE risk among COCPs)
  • Arterial thrombosis — stroke, MI (especially with smoking, hypertension, migraine with aura)
  • Hypertension (monitor BP)
  • Breast cancer (marginally increased relative risk — absolute risk very small; reverses after stopping)
  • Cervical cancer (small increase — likely confounding)
  • Liver tumours (rare)

Contraindications

Available Indian Brands

BrandManufacturerPrice (approx)
Loette (EE 20 + LNG 100)Wyeth/Pfizer21 tab ₹95
Ovral-L (EE 30 + LNG 150)Wyeth/Pfizer21 tab ₹95
Femilon (EE 20 + Desogestrel 150)Organon21 tab ₹120
Mala-N (EE 30 + Norethindrone)HLL28 tab ₹5 (govt)

Monitoring Required

Patient Counseling Points

Stop Googling drug references mid-consultation

EasyClinic auto-flags Loette interactions, renal cutoffs, and pregnancy warnings the moment you write the prescription. Built-in safety net for every Indian doctor.

Start 7-Day Free Trial

Clinically reviewed by: Dr. Anitha Krishnamurti, DGO, DNB (Obstetrics & Gynaecology), Senior Consultant

Last reviewed: 2026-04-01

References

  • WHO Medical Eligibility Criteria for Contraceptive Use (MEC) 5th edition
  • FOGSI Guidelines on Contraception
  • BNF — Combined Oral Contraceptives
  • FSRH UK Guidance 2023
Disclaimer: This information is for clinical reference only. It is not exhaustive and does not substitute clinical judgement. Always verify current dosing against the manufacturer's prescribing information and current treatment guidelines. Drug prices are approximate and may vary.